The second person Chen Xia wanted to deal with was a very important position in the company, "Financial Manager".
It just so happened that the head of the Finance Department of the People's Hospital, Aunt Fei Meilan, had just retired at the age of 55.
In the entire People's Hospital, if you were to say who Chen Xia fears the most, it would be Aunt Fei. This old aunt is so damn smart, so smart that she can see through people's hearts every time.
At the beginning, every time Chen Xia went to the finance department to collect money after distributing benefits to the hospital, he was like a mouse seeing a cat when he saw Fei Meilan.
Moreover, over the years, Chen Xia has never seen the old aunt make a financial mistake. Her work ability is absolutely top-notch.
It is such a pity that such a smart, capable and energetic old lady goes to the park to practice Tai Chi after retirement.
So when Chen Xia came to her home and asked her to be the Chinese financial manager of the new company, she agreed immediately.
Her husband, Wu Shunyan, the director of the ENT department of the People's Hospital, was so happy that he held Vice President Chen's hand tightly and burst into tears of gratitude.
Please don't get me wrong, Director Wu is not trying to flatter his boss, but after Aunt Fei retired, she was dissatisfied with everyone at home every day, scolding people at every turn and throwing things around.
For Director Wu, life is simply unbearable. Sometimes he is woken up in the middle of the night by his wife's scolding. If this continues, he will suffer from nervous breakdown.
It's no wonder. Someone who has worked for many years, especially a middle-level leader for many years, feels like his soul has been taken away once he retires. He has lost all his spiritual support and can only vent at home.
Just like the group of old men and women in the Yuezhou Veteran Cadre Bureau, once they retire, they lose their former elegance and become like shrews. This is the legendary "retirement syndrome".
Next, Chen Xia found Robson Walton's contact information and went to Yuezhou Post and Telecommunications Bureau to make a long-distance call to tell him that he was going to start work.
The price was 20 yuan per minute, and the two of them fought for half an hour. When they came out, they paid 600 yuan, which was almost half a year's salary for an ordinary worker.
Many employees at the Post and Telecommunications Bureau were discussing behind his back whether Vice President Chen had embezzled money. Where did he get so much money?
While Chen Xia was busy with the acquisition and reorganization of the textile factory, England's "The Lancet" published two papers in the same issue of the magazine.
"Research on the Clinical Application of Nebulized Inhalation Drugs" and "The Latest Diagnosis and Treatment Ideas for Childhood Asthma".
The signed authors are Hong Kong Margaret Hospital and Yuezhou People's Hospital in China, and the reporting author's unit is Hong Kong Pumpkin Vine Pharmaceutical Company.
The two papers instantly caused an uproar in medical circles around the world because they completely overturned the current clinical treatment of asthma, especially childhood asthma.
The viewpoint put forward is that asthma treatment is no longer based on oral or intravenous hormones, but instead on nebulized inhalation of a hormone. The advantages and efficacy of nebulized inhalation are listed in detail, and a series of comparative experimental data are listed.
At the same time, the guidelines also clearly changed the treatment of asthma from the previous "anti-infection treatment" to the new "anti-inflammatory and anti-allergic treatment" approach.
Change the symptomatic treatment during an attack to a regular treatment plan that focuses on preventing attacks.
This has caused a huge response in pediatrics and respiratory departments in various countries.
With the development of medicine and the increasing medical requirements of patients, doctors and patients have gradually discovered that the old asthma treatment model has many side effects and even seriously endangers human health.
For example, among adults, long-term and repeated use of hormones can easily lead to many complications.
Such as infection, hypertension, hyperglycemia, osteoporosis, rebound after drug withdrawal, aseptic necrosis of femoral head, obesity, mental excitement, peptic ulcer, etc.
In pediatrics, long-term use of hormones to treat asthma and bronchitis leads to particularly obvious Cushing's reaction in children, and endocrine disorders cause moon face, hirsutism, and obesity.
The originally pretty little handsome boys and beautiful girls have gradually turned into "ugly monsters" who are dark, fat and hairy. How many parents can stand it?
In the 1980s, the world was generally peaceful, there was no war, and all countries focused on economic development. Ordinary people began to have more money, and their demands for medical care were getting higher and higher.
Just when doctors and patients could no longer tolerate the situation and urgently needed change, these two papers appeared in time.
This revolutionary treatment, with clear experimental data showing that this latest treatment method is more effective and has fewer side effects, has filled all clinicians with curiosity.
At this time, the good relationship between Pumpkin Vine Pharmaceuticals and Pfizer in the United States, GlaxoSmithKline in England, and Takeda Pharmaceutical in Japan came into play.
Because the distributors (medical representatives) of these three companies are almost all over the world, they have the doctor information of famous hospitals and even unknown hospitals in the world, and they are familiar with all the medical representatives.
So invitation cards were sent to various experts and professors.
On December 12, 1986, the Chinese government invited him to attend the event.
The "International Asthma Academic Forum" and the "International Allergic Disease Academic Forum" co-organized by Xiangjiang Pumpkin Vine Pharmaceutical Company, Margaret Hospital and Yuezhou People's Hospital will be held in Yuezhou, China.
Doctors, medical experts and professional professors from all over the world are welcome to attend the conference, and new clinical drugs will be exhibited at the conference.
The medical community is a very small circle. After the invitation letter was delivered, everyone began to communicate frequently in private.
After all, "Xiangjiang Pumpkin Vine Pharmaceutical Company" is really an unknown small company, and Xiangjiang Margaret Hospital and Yuezhou Hospital are even unheard of.
But the subsequent news made everyone feel that Pumpkin Vine Pharmaceuticals might be extraordinary.
The discovery of Helicobacter pylori and the invention of the "quadruple therapy" were jointly researched and invented by the little-known "Xiangjiang Pumpkin Vine Company" and "Yuezhou Hospital".
This discovery and invention is extraordinary. It has revolutionized the research on the treatment of stomach diseases and is definitely a "Nobel Prize-level" major breakthrough.
Not to mention those experts and professors from famous hospitals.
Even in small, remote hospitals in Africa, traditional medicines and thinking have been abandoned in the treatment of stomach problems, and treatment is now conducted entirely in accordance with the "Diagnosis and Treatment Guidelines" jointly developed by the "Xiangjiang Pumpkin Vine Company" and the "Yuezhou Hospital".
Then everyone suddenly discovered that the drug "Sildenafil" for the treatment of ED that GlaxoSmithKline Pharmaceuticals has been vigorously promoting recently was actually invented by "Hong Kong Pumpkin Vine Company".
Although the production of Tsuen Wan Pharmaceutical Factory was delayed due to special reasons, the related advertisements have been everywhere and known to the world.
Can a company that can continuously launch innovative drugs and subvert clinical guidelines be an ordinary company?
Gradually, more and more doctors became interested in this invitation...
Continue read on readnovelmtl.com
